Does uremia interfere with HbA1c results in the FPLC method with Mono S cation exchanger?

Clin Chim Acta. 1998 May 8;273(1):69-79. doi: 10.1016/s0009-8981(98)00030-8.

Abstract

To study the effect of uremia on hemoglobin A1c determination by the Mono S FPLC method, samples from uremic patients, with and without diabetes, and controls, were analysed with a modified chromatography with enhanced resolution. Besides specific HbA1c, four minor peaks could be seen, included in routine HbA1c values. Two of these differed in concentration in the patient groups studied: a shoulder-like peak close to the specific HbA1c (S fraction) and a slightly less cationic minor peak (M fraction). Both S and M peaks were higher in uremic than in nonuremic subjects, but the M peak was associated more with diabetes. In the nondiabetic group, the mean routine HbA1c value was 0.8% units higher in uremic than nonuremic individuals. The specific HbA1c was nondependent on uremia. Thus, in uremic patients, there seems to be falsely elevated HbA1c values, mainly because of small interfering hemoglobin fractions, not specific HbA1c.

MeSH terms

  • Adult
  • Aged
  • Artifacts
  • Cation Exchange Resins
  • Chromatography, Ion Exchange / methods*
  • Diabetes Complications
  • Diabetes Mellitus / blood*
  • Glycated Hemoglobin / analysis*
  • Humans
  • Middle Aged
  • Uremia / blood*
  • Uremia / complications

Substances

  • Cation Exchange Resins
  • Glycated Hemoglobin A